IT dept detects Rs 400-cr black income after raids on Hyderabad-based pharma group
The Income Tax Department has detected “unaccounted” income of about Rs 400 crore after raids on a major pharmaceutical group based in Hyderabad, the Central...
Pharmaceutical
Biocon Biologics elevates Shreehas Tambe as deputy chief executive officer
New Delhi: Biocon Biologics on Monday said it has elevated Shreehas Tambe to the position of deputy chief executive officer with immediate effect. Prior to...
EU audits Serum Institute as AstraZeneca looks to boost supplies to the bloc: Source
Europe’s drug regulator is auditing the manufacturing site of the Serum Institute of India (SII), a source with knowledge of the matter said, a necessary...
Chaos reigns as CoWIN keeps shutting down
New Delhi: The excitement for getting vaccinated on Day 1 of the third phase of massive immunization drive turned into a chaos after the CoWIN...
Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. announced on Monday the European Medicines Agency‘s Committee for Medicinal Products for Human Use (CHMP) has recommended...
Oxford University Covid lab suffers cyber attack
London: Oxford University has confirmed that one of its laboratories involved in Covid-19 research suffered cyberattack after an investigation by Forbes suggested that hackers were...
Adityanath launches communicable disease control drive in UP
Lucknow: Uttar Pradesh Chief Minister Yogi Adityanath on Sunday emphasised on prevention as he launched the communicable disease control drive and Dastak Abhiyan in Varanasi....
How Johnson & Johnson’s vaccine differs from Pfizer’s and Moderna’s
A third effective weapon was added to America’s arsenal against the coronavirus Saturday when the Food and Drug Administration granted emergency use authorization for a...
Johnson & Johnson’s planned coronavirus vaccine trials to include infants
Johnson & Johnson plans to test its coronavirus vaccine in infants and even in newborns, as well as in pregnant women and in people who...
AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times
AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company’s shares soared on the back...